Mice with systemic FGF2 deficiency developed less severe cardiac hypertrophy in response to aortic banding (142) in line with the role of FGF2 as cardiomyocyte growth factor, whereas cardiac angiogenesis was not evaluated in this study. This evidence concerns the gene FGF2 and cardiac hypertrophy.